Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics to Present at Upcoming Investor Conferences




Travere Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:

BofA Securities Health Care Conference
Wednesday, May 15, 2024, at 8:00 a.m. PT

Jefferies Global Healthcare Conference
Wednesday, June 5, 2024, at 3:00 p.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Contact Info

Media:
888-969-7879                                        
mediarelations@travere.com
Investors:
888-969-7879                                        
IR@travere.com